1. Home
  2. PRCT vs ADNT Comparison

PRCT vs ADNT Comparison

Compare PRCT & ADNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PROCEPT BioRobotics Corporation

PRCT

PROCEPT BioRobotics Corporation

HOLD

Current Price

$25.22

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Logo Adient plc

ADNT

Adient plc

HOLD

Current Price

$21.74

Market Cap

1.7B

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRCT
ADNT
Founded
2009
2016
Country
United States
Ireland
Employees
N/A
N/A
Industry
Medical Specialities
Auto Parts:O.E.M.
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.7B
IPO Year
2021
2016

Fundamental Metrics

Financial Performance
Metric
PRCT
ADNT
Price
$25.22
$21.74
Analyst Decision
Buy
Buy
Analyst Count
11
11
Target Price
$35.44
$25.59
AVG Volume (30 Days)
1.1M
768.7K
Earning Date
04-29-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
1.71
N/A
EPS
N/A
N/A
Revenue
$308,054,000.00
$17,439,000,000.00
Revenue This Year
$31.34
$2.71
Revenue Next Year
$24.52
$2.36
P/E Ratio
N/A
N/A
Revenue Growth
37.22
7.56
52 Week Low
$19.35
$11.09
52 Week High
$64.89
$27.32

Technical Indicators

Market Signals
Indicator
PRCT
ADNT
Relative Strength Index (RSI) 50.21 57.21
Support Level $22.81 $18.69
Resistance Level $28.57 $21.76
Average True Range (ATR) 1.24 0.88
MACD 0.18 0.20
Stochastic Oscillator 65.64 70.74

Price Performance

Historical Comparison
PRCT
ADNT

About PRCT PROCEPT BioRobotics Corporation

PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. The company develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.

About ADNT Adient plc

Adient began trading Oct. 31, 2016, when Johnson Controls spun off its automotive experience segment. Adient is a leading seating supplier to the industry with about a midteens share of the global market including unconsolidated joint venture business. Its share in China is around 20%, down from about 45%, following the sale of its main joint venture there at the end of fiscal 2021. Unconsolidated revenue from joint ventures was about $3.5 billion in fiscal 2025 and consolidated China revenue was $1.3 billion. The company is headquartered in Ireland but has corporate offices in the Detroit area. Fiscal 2025 (Sept. 30 year-end) consolidated revenue, which excludes joint venture sales, was $14.5 billion.

Share on Social Networks: